4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-072771
Chief Development Officer sold 10,000 shares at $32.00 ($320,000)
- Chief Development Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2023-12-22 | Option exercise 10b5-1 | +10,000 | $19.26 | $192,600 | 16,643 | D |
| Guyer William Chief Development Officer | 2023-12-22 | Sale 10b5-1 | −10,000 | $32.00 | $320,000 | 6,643 | D |
| Derivatives | |||||||
| Guyer William Chief Development Officer | 2023-12-22 | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 90,000 | D | ||
| Open-market sales · 10,000 sh · avg $32.00 · $320,000 | |||||||
Loading xslF345X05/ownership.xml…